Associate Director
CurrentSupport to drug development activities in women's health and OTC product development including protocol development, sample size estimation, CDISC dataset devlopment, Phase I (PK, PD, BA, and Thorough QTc studies), Phase II, and Phase III trials. As well as direct/indirect interactions with CROs and support to external clinical research.